Genalyte
PrivateLast Round
Series C
Extension
Apr 21, 2023
Total Funding Raised
$110.8M
Momentum Score
50 /100
Company Overview
Genalyte is a healthcare technology company that offers a diagnostic testing system featuring rapidly deployable mobile laboratories capable of delivering real-time diagnostics in under thirty minutes, enhancing patient care and optimizing resource use across the healthcare system.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Sensors, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genalyte Comps
Public and private peers based on sector, stage, and business model.
Genalyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 21, 2023 | ||||
| VC Round | Jan 11, 2021 | ||||
| Series D | Nov 21, 2016 | ||||
| Series C | Aug 18, 2015 | ||||
| Grant | Aug 20, 2013 | ||||
Grant | Dec 11, 2012 |
Genalyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series C Extension, VC Round, Series D, Series B |
| National Cancer Institute | Grant |
| Khosla Ventures | Series C Extension, VC Round, Series C, Series D |
| Provenio Capital | Series C Extension, VC Round |
| Boutique Venture Partners | Series C Extension |
| HBM Healthcare Investments | Series C Extension |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Merlin platform for diagnostic testing is in development.
- Apr 16, 2025
Attended Abu Dhabi Global Health Week 2025 and announced a strategic partnership.
Genalyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genalyte's valuation, stock price, and market status.
